|
|
Meta-analysis of the incidence of reproductive adverse events in the treatment of rheumatoid arthritis by Tripterygium wilfordii |
GAO Yang1 BAI Jian2 WANG Renyi2 ZHAO Yanpeng2 YANG Zhengzheng3 WANG Xixi2 WANG Hailong3 |
1.Department of Rheumatology, Guang′anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China;
2.Graduate School, Guizhou University of Traditional Chinese Medicine, Guizhou Province, Guiyang 550025, China;
3.Department of Rheumatology, Guang′anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China |
|
|
Abstract Objective To systematic evaluate reproductive toxicity adverse of Tripterygium wilfordii in the treatment of patients with rheumatoid arthritis. Methods PubMed, EMbase, Cochrane Library, Web of Science, CNKI, CBM, Wanfang, VIP and other databases were searched. From the establishment of the database to January 2020, all randomized controlled trials of Tripterygium wilfordii in the treatment of rheumatoid arthritis were searched for the key words of “Tripterygium wilfordii multiglucoside”, “Tripterygium wilfordii polyglycoside”, “Tripterygium wilfordii”, “rheumatoid arthritis”, “rheumatoid arthritis”, “arthralgia syndrome” and “arthralgia”. According to the literature of reproductive toxicity, Jadad scale was used to score and RevMan5.3 software was used to analyze the incidence of reproductive toxicity. Results A total of 1454 articles were searched and analyzed. Twenty-two of them met the inclusion criteria. Total sample size was 2085 cases, including 924 cases in experimental group (Tripterygium wilfordii) and 1161 cases in control group (non Tripterygium wilfordii). Compared with control group, the incidence of menstrual disorder, amenorrhea and sperm motility decreased in experimental group increased (RR = 4.58, 95%CI: 2.65-7.92, P < 0.000 01; RR = 4.97, 95%CI: 1.81-13.63, P = 0.002; RR = 11.02, 95%CI: 2.73-44.44, P = 0.0007). Conclusion The side effects of reproductive system toxicity will appear in patients using Tripterygium wilfordii to a certain extent. However, due to the limited literature available, the above results need to be further verified by higher quality randomized controlled trials.
|
|
|
|
|
[1] 朱光昭,韩晓晨,王翰洲,等.雷公藤治疗类风湿关节炎骨破坏的系统评价和Meta分析[J].中国中药杂志,2019, 44(15):3358-3364.
[2] 葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2013:364-367.
[3] Tao XL,Sun Y,Dong Y,et al. A prospective controlled double-blind cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis [J]. Chin Med J,1989, 102(5):327-332.
[4] 胡秀慧.中西医结合治疗类风湿性关节炎72例疗效观察[J].浙江中医学院学报,1995,19(4):24-25.
[5] 费立升,刘加军.雷公藤多甙与转移因子联合治疗类风湿性关节炎疗效观察[J].康复与疗养杂志,1997,12(2):15-16.
[6] 孙瑞华,林宗广.“正清风痛宁”治疗类风湿性关节炎38例疗效观察[J].上海中医药杂志,1999(2):21-23.
[7] Tao XL,Younger J,Fan FZ,et al. Benefit of an extract of tripterygium wilfordii hook F in patients with rheumatoid arthritis:a double-blind,placebo-controlled study [J]. Arthr Rheumat,2002,46(7):1735-1743.
[8] 王夜,靳端阳,马艳平.痹痛安胶囊治疗类风湿性关节炎100例疗效观察[J].中国中西医结合杂志,2003,23(7):511-513.
[9] 沈瑞子,邱仁斌,邓惠文.青风藤汤治疗类风湿性关节炎45例疗效观察[J].新中医,2004,39(9):26-27.
[10] 杨文炎,赵秀玲,崔秀兰,等.加味四妙勇安胶囊治疗类风湿性关节炎的临床研究[J].光明中医,2004,19(5):40-42.
[11] 叶天申,谢文霞,张劲军.巴布剂穴位贴敷治疗活动期类风湿性关节炎33例临床研究[J].江西中医学院学报,2005,17(6):23-24.
[12] 谌曦,李华.正清风痛宁治疗类风湿性关节炎的临床研究[J].安徽中医学院学报,2005,24(1):9-11.
[13] 刘晋华,张喜旺,尹晓飞,等.祛风活络丸治疗类风湿性关节炎临床疗效评价[J].中国药师,2006,9(5):425-427.
[14] 涂胜豪,胡永红.雷公藤治疗类风湿关节炎的疗效和生活质量评价[J].湖南中医学院学报,2006,26(2):25-27.
[15] 邹蕴珏.桂枝芍药知母汤加味治疗类风湿关节炎30例临床观察[J].中国中医急症,2007,16(6):672-673.
[16] 徐长松,周学平.补肾清络方治疗类风湿性关节炎临床研究[J].吉林中医药,2008,28(2):110-111.
[17] 王慧.毒痹消治疗类风湿关节炎临床观察[J].天津药学,2008,20(1):44-46.
[18] 李亚萍.正清风痛宁缓释片治疗类风湿关节炎疗效观察[J].中医正骨,2008,20(4):50.
[19] Mansky RG,Wilson M,Fleischmann R,et al. Comparison of tripterygium wilfordii hook F versus sulfasalazine in the treatment of rheumatoid arthritis [J]. Ann Internal Med,2009,151(4):229.
[20] 陈英,曹晶晶,杨卫杰.电针加艾条温和灸治疗类风湿关节炎40例[J].光明中医,2011,26(6):1173-1174.
[21] 杨竹.雷公藤片治疗类风湿性关节炎74例[J].中国药业,2011,20(14):76-77.
[22] Lv QW,Zhang W,Shi Q,et al. Comparison of tripterygium wilfordii hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA):a randomised controlled clinical trial [J]. Ann Rheumat Dis,2014,74(6):1078-1086.
[23] 赵晋辉,李晓梅.类风湿专方治疗类风湿关节炎临床观察[J].山西中医,2014,30(2):37-38.
[24] 袁作武,游济洲,陈海丽.中药配伍对雷公藤治疗育龄女性类风湿关节炎减毒增效的研究[J].风湿病与关节炎,2018,7(7):28-32.
[25] 姜泉,王海隆,巩勋,等.类风湿关节炎病证结合诊疗指南[J].中医杂志,2018,59(20):1794-1800.
[26] 王翰洲,朱光昭,杨豫正,等.雷公藤多苷片治疗类风湿关节炎作用于IL-23/IL-17轴相关细胞因子的系统评价和meta分析[J].中国医药导报,2020,17(12):128-132. |
|
|
|